Home > Cashflow Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Cashflow Statement

BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹12 Cr₹5.19 Cr₹5.83 Cr₹-1.88 Cr₹-18 Cr
Adjustment ₹7.88 Cr₹5.50 Cr₹3.82 Cr₹-20 Cr₹5.42 Cr
Changes In working Capital ₹-15 Cr₹-0.80 Cr₹-23 Cr₹-12 Cr₹12 Cr
Cash Flow after changes in Working Capital ₹5.08 Cr₹9.90 Cr₹-14 Cr₹-34 Cr₹-1.10 Cr
Cash Flow from Operating Activities ₹4.95 Cr₹9.73 Cr₹-14 Cr₹-34 Cr₹-1.10 Cr
Cash Flow from Investing Activities ₹-7.49 Cr₹-6.54 Cr₹-5.35 Cr₹33 Cr₹3.53 Cr
Cash Flow from Financing Activities ₹10 Cr₹-4.81 Cr₹12 Cr₹7.27 Cr₹-2.44 Cr
Net Cash Inflow / Outflow ₹7.64 Cr₹-1.63 Cr₹-6.68 Cr₹5.78 Cr₹0.00 Cr
Opening Cash & Cash Equivalents ₹0.17 Cr₹1.80 Cr₹8.48 Cr₹2.70 Cr₹2.70 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹7.81 Cr₹0.17 Cr₹1.80 Cr₹8.48 Cr₹2.70 Cr

Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹208.6 Cr -1% -11.8% -18% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,625.0 Cr 3% 2.3% 68.2% Stock Analytics
CIPLA ₹112,938.0 Cr 2.5% 0.4% 71.7% Stock Analytics
DIVIS LABORATORIES ₹101,315.0 Cr -1.6% -7% 23.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,276.9 Cr -0.2% -4.9% 40.3% Stock Analytics
ZYDUS LIFESCIENCES ₹93,921.9 Cr 5% 10.4% 109.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-1%

-11.8%

-18%

SENSEX

1.3%

2.6%

24%


You may also like the below Video Courses